Li, Xin

Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12

Chi, X., Yang, P., Zhang, E., Gu, J., Xu, H., Li, M., Gao, X., Li, X., Zhang, Y., Xu, H., et al. (2019) · Cancer Medicine

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 75

Factors associated with rapid improvement in visual acuity in patients with Leber’s hereditary optic neuropathy after gene therapy

Liu, H., Yuan, J., Zhang, Y., Tian, Z., Li, X., Wang, D., Du, Y., Song, L., & Li, B. (2020) · Acta Ophthalmologica

Glaucoma and retinal disordersRetinal Development and Disorders

Cited by 35

A Phase 1 First-in-Human Monotherapy Study of F182112, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory Multiple Myeloma

Sun, M., Qi, J., Qiu, L., Jin, J., Li, X., Wei, Y., Zhang, G., Liu, X., & Yin, S. (2023) · Blood

Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research

Cited by 5